'Buffalo hump' in men with HIV-1 infection

Lancet

Volumn 351, Issue 9106, 1998, Pages 867-870

  Lo, Joan C ^a,b   Mulligan, Kathleen ^a   Tai, Viva W ^a   Algren, Heather ^a   Schambelan, Morris ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHOLESTEROL; DEXAMETHASONE; GLUCOSE; HYDROCORTISONE; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ABSORPTIOMETRY; ARTICLE; BODY MASS; BUFFALO HUMP; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LIPID STORAGE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; X RAY ANALYSIS;

EID: 0032554569     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11443-X     Document Type: Article

References (23)

1. 1 Ruane PJ. Atypical accumulation of fatty tissue [abstr]. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy 1997: 1-185.
2. 2 Hengel RL, Watts NB, Lennox JL. Benign symmetric lipomatosis associated with protease inhibitors. Lancet 1997; 350: 1596.
3. 3 Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990; 51: 1106-12.
4. 4 Murphy BEP. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein radioassay. J Clin Endocrinol Metab 1967; 27: 973-90.
5. 5 Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr 1997; 15: 43-48.
6. 6 Pavlatos FC, Smilo RP, Forsham PH. A rapid screening test for Cushing's syndrome. JAMA 1965; 193: 96-99.
7. 7 Nugent CA, Nichols T, Tyler FH. Diagnosis of Cushing's syndrome. Arch Intern Med 1965; 116: 172-76.
8. 8 Fok ACK, Tan KT, Jacob E, Sum CF. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome. Steroids 1991; 56: 549-51.
9. 9 Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 1979; 28: 955-77.
10. 10 Findling JW, Doppman JL. Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 1994; 23: 511-37.
11. 11 Mengden T, Hubmann P, Muller J, Greminger P, Vetter W. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Invest 1992; 70: 545-48.
12. 12 Yanovski JA, Cutler GB. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 1994; 23: 487-509.
13. 13 Rebuffé-Scrive M, Krotkiewski M, Elfverson J, Björntorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 1988; 67: 1122-28.
14. 14 Peeke PM, Chrousos GP. Hypercortisolism and obesity. Ann NY Acad Sci 1995; 771: 665-76.
15. 15 Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obesity 1996; 20: 291-302.
16. 16 Rebuffé-Scrive M, Brönnegard M, Nilsson A, Eldh J, Gustafsson J, Björntorp P. Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 1990; 71: 1215-19.
17. 17 Bujalska I, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997; 349: 1210-13.
18. 18 Ramsay TG. Fat cells. Endocrinol Metab Clin North Am 1996; 25: 847-70.
19. 19 Schambelan M, Grunfeld C. Endocrinologic manifestations of HIV infection. In: Sande MA, Volberding PA, editors. The Medical Management of AIDS, 4th ed. Philadelphia: WB Saunders, 1995; 345-57.
20. 20 Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74: 1045-52.
21. 21 Hellerstein MK, Grunfeld C, Wu K et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993; 76: 559-65.
22. 22 Fujioka S, Matsuzawa Y, Tokunaga K, Tarai S. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
23. 23 Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 1995; 748: 399-406.